---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-096536"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2023-12-18T23:59:59+00:00"
generated_at: "2026-06-07T11:11:46.116763+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Oramed appoints Dr. Daniel Aghion to board of directors effective Jan 1, 2024

## Summary
- Board size increased by one; Dr. Aghion fills resulting vacancy effective January 1, 2024.
- Aghion is a neurosurgeon at Memorial Neuroscience Institute since 2016.
- Compensation will match fees paid to other non-executive directors.
- No arrangements or transactions requiring disclosure under Item 404(a) in connection with appointment.

## SEC filing metadata
- accession: 0001213900-23-096536
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2023-12-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390023096536/0001213900-23-096536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390023096536/ea190226-8k_oramedpharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-096536
- JSON: https://secwatch.observer/filing/0001213900-23-096536.json
- Plain text: https://secwatch.observer/filing/0001213900-23-096536.txt

## Key facts
- Executive change
  Dr. Daniel Aghion was appointed as director at ORAMED PHARMACEUTICALS INC..
  - Action: appointed
  - Role: director
  source text: On December 18, 2023, Oramed Pharmaceuticals Inc. (the “Company”) increased the size of its Board of Directors (the “Board”) by one and appointed Dr. Daniel Aghion to serve as a director to fill the resulting vacancy, effective as of January 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000121390023096536/0001213900-23-096536-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.